Your search returned 2 results.

Results
	1.	JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. [electronic resource] by Tuttle, Katherine R Brosius, Frank C Adler, Sharon G Kretzler, Matthias Mehta, Ravindra L Tumlin, James A Tanaka, Yoshiya Haneda, Masakazu Liu, Jiajun Silk, Maria E Cardillo, Tracy E Duffin, Kevin L Haas, Joseph V Macias, William L Nunes, Fabio P Janes, Jonathan M Producer: 20191021 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. [electronic resource] by Wallace, Daniel J Furie, Richard A Tanaka, Yoshiya Kalunian, Kenneth C Mosca, Marta Petri, Michelle A Dörner, Thomas Cardiel, Mario H Bruce, Ian N Gomez, Elisa Carmack, Tara DeLozier, Amy M Janes, Jonathan M Linnik, Matthew D de Bono, Stephanie Silk, Maria E Hoffman, Robert W Producer: 20180927 In: Lancet (London, England) vol. 392 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search